Clinical trials for Neurofibromatosis type 1

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Neurofibromatosis type 1. For all clinical trials, go to clinical trials search

This list shows clinical trials for Neurofibromatosis type 1

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Neurofibromatosis type 1
Title Recruitment status Location
Effect of Implant Position on Magnetic Resonance Image Distortion Recruiting United Kingdom
Reliability of Functional Outcome Measures in Neurofibromatosis 1 Not recruiting United Kingdom
Evaluation of [11C]-methionine positron emission computerised tomography (PET CT) in diagnosing neurofibromatosis 1(NF1) - malignant peripheral nerve sheath tumours (MPNST) - Methionine PET Not Recruiting United Kingdom
Early phase triple blind placebo controlled RCT of simvastatin treatment for autism in young children with Neurofibromatosis Type 1 Not Recruiting United Kingdom
A CLINICAL TRIAL OF THE INTRA-TUMOURAL CONCENTRATION AND ACTIVITY OF NILOTINIB IN INTRA-CUTANEOUS SCHWANNOMAS - PHNT NilotinibNF2 Authorised United Kingdom
Investigation of the intra-tumoural concentration and activity of sorafenib in cutaneous schwannomas - Sorafenib in NF2 Authorised United Kingdom
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas Recruiting United States
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma Recruiting United States
Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments Recruiting United States
The Cognitive Variability in NF1 and TSC Monozygotic Twins Recruiting Netherlands

Page last reviewed: 16/03/2015

Next review due: 30/09/2017